From February, the vaccine ‘Nuvaxovid’ from Novavax will also be vaccinated in Germany. Certain people should get a spade as a priority.
Novavax’s ‘Nuvaxovid’ vaccine has been approved in the European Union since the end of 2021 as one of a total of five vaccines against the coronavirus. It has been clear since mid-January 2022 that the first deliveries should arrive in Germany at the end of February – experts are anticipating high demand, since the Novavax vaccine is particularly suitable for people who have not been vaccinated out of skepticism about modern mRNA and vector vaccines can be an option.
At the end of February, 1.75 million cans are initially expected – 3.25 million cans are to follow in 2022. According to information from HEIDELBERG24*, the Novavax doses, which will arrive in Germany in February, should be given priority to very specific people. That’s right, the first doses of Novavax vaccine are intended for people* who are health professionals. Which professions these are is in the linked article. * HEIDELBERG24 is part of IPPEN.MEDIA.
